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Abstract
Invadopodia are membrane protrusions that facilitate matrix degradation and cellular invasion. Although lipids have been
implicated in several aspects of invadopodia formation, the contributions of de novo fatty acid synthesis and lipogenesis
have not been defined. Inhibition of acetyl-CoA carboxylase 1 (ACC1), the committed step of fatty acid synthesis, reduced
invadopodia formation in Src-transformed 3T3 (3T3-Src) cells, and also decreased the ability to degrade gelatin. Inhibition of
fatty acid synthesis through AMP-activated kinase (AMPK) activation and ACC phosphorylation also decreased invadopodia
incidence. The addition of exogenous 16:0 and 18:1 fatty acid, products of de novo fatty acid synthesis, restored
invadopodia and gelatin degradation to cells with decreased ACC1 activity. Pharmacological inhibition of ACC also altered
the phospholipid profile of 3T3-Src cells, with the majority of changes occurring in the phosphatidylcholine (PC) species.
Exogenous supplementation with the most abundant PC species, 34:1 PC, restored invadopodia incidence, the ability to
degrade gelatin and the ability to invade through matrigel to cells deficient in ACC1 activity. On the other hand, 30:0 PC did
not restore invadopodia and 36:2 PC only restored invadopodia incidence and gelatin degradation, but not cellular invasion
through matrigel. Pharmacological inhibition of ACC also reduced the ability of MDA-MB-231 breast, Snb19 glioblastoma,
and PC-3 prostate cancer cells to invade through matrigel. Invasion of PC-3 cells through matrigel was also restored by 34:1
PC supplementation. Collectively, the data elucidate the novel metabolic regulation of invadopodia and the invasive
process by de novo fatty acid synthesis and lipogenesis.
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Introduction
Podosomes and invadopodia are membrane protrusions at
focalized sites of polymerized actin that coordinate the invasive
properties or normal and tumor cells, respectively [1]. In addition
to polymerized actin, both structures comprise a complex
assortment of proteins including actin-modifying proteins, inte-
grins, proteases, multiple kinases, and several scaffolding proteins
[2]. The integration of these components facilitates the invasive
process through coordinated proteolysis of the extracellular matrix
[3]. Podosomes have been visualized on invading cells ex vivo and
disruption of podosome architecture decreases the ability of cells to
invade [1,4]. Because of their complex makeup, both structures
can be regulated through multiple mechanisms including, but not
limited to, kinase signaling and reactive oxygen species [1,5].
Given the complex architecture of podosomes and invadopodia it
is likely that other processes underlying podosome and invadopo-
dia construction remain to be elucidated.
The dynamic cell membrane is what connects the extracellular
function of podosomes and invadopodia to their intracellular
architecture. Several pieces of evidence support a role for lipids
and cellular membranes in the formation of podosome and
invadopodia. First, the phosphoinositide (PI) class of lipids is
critical to the formation of podosomes and invadopodia [6,7].
Specifically, invadopodia formation is initiated when PI(3,4)P2
accumulates at focal adhesions following Src activation [8].
Related to this, the p110a catalytic subunit of PI3-kinase is
necessary for the formation of invadopodia in breast MDA-MB-
231 cells [9]. Given this, it is no surprise that several podosome
and invadopodia-associated proteins have lipid-binding domains.
For example, tyrosine kinase substrate 5 (Tks5) has a phox
homology (PX) domain that facilitates interactions with PI(3)-P
and PI(3,4)-P2 [10]. Cholesterol is another lipid that has been
implicated in invadopodia formation. Particularly, cholesterol
levels regulate caveolin-1 interactions and lipid raft formation to
provide an appropriate scaffold for invadopodia to form [11,12].
Lastly, actin polymerization is dependent on appropriate
membrane curvature and the function of membrane associated
BAR (bin-amphiphysin-Rvs) domain proteins [13]. Collectively,
this body of literature provides compelling evidence that lipid
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mediating the formation and activity of podosomes and
invadopodia.
The de novo fatty acid synthesis pathway is an important
component of the metabolic phenotype of tumor cells. Fatty acids
are synthesized from acetyl-CoA and malonyl-CoA by fatty acid
synthase (FASN) [14]. The rate limiting step of the pathway,
however, is the production of malonyl-CoA by acetyl-CoA
carboxylase 1 (ACC1) for both synthesis and elongation of fatty
acids [15,16]. Although the pathway provides fatty acid that can
be used for multiple processes, the majority of de novo synthesized
fatty acid is incorporated into phospholipids for membrane
biogenesis [14,17]. Thus, the fatty acid synthesis pathway is a
significant contributor to the cellular membrane. A major fraction
of newly synthesized fatty acids localize to lipid rafts, suggesting
that they regulate crucial signaling and membrane-based processes
[17]. As a result, the fatty acid synthesis pathway could provide a
metabolic cue for membrane-mediated processes like podosome
and invadopodia facilitated invasion.
A body of literature has demonstrated that the expression and
activity of enzymes in the fatty acid synthesis pathway are
significantly increased in most cancers [18]. Moreover, the
expression levels of ACC1 and FASN have been correlated with
aggressive disease and poor outcome [19,20,21,22,23,24,25,26,
27,28,29], suggesting an important role for this pathway in
advanced disease. Because invadopodia are membrane protrusions
and aspects of lipids and lipid metabolism have been implicated in
their function, we investigated the role of de novo fatty acid synthesis
in invadopodia formation and function. Here we describe the
novel connection between ACC1 activity, fatty acid synthesis, and
invadopodia function in Src-transformed 3T3 cells, specifically,
through modulation of fatty acid and phospholipid synthesis.
These results provide a novel mechanism by which de novo
lipogenesis regulates the invasive process of tumor cells.
Materials and Methods
Materials
5-(Tetradecyloxy)-2-furoic acid (TOFA) and 5-Aminoimidazole-
4-carboxamide ribonucleotide (AICAR) was purchased from
Calbiochem (La Jolla, CA). CP-640186 was a generous gift from
Pfizer (Groton, CT). Fatty acid free bovine serum albumin (BSA),
16:0 fatty acid sodium salt, BSA-18:1 fatty acid, and all standard
chemicals were purchased from Sigma-Aldrich (St. Louis, MO). 1-
myristoyl-2-palmitoyl-sn-glycero-3-phosphocholine (30:0 PC), 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (34:1 PC), and
1,2-dioleoyl-sn-glycero-3-phosphocholine (36:2 PC) were pur-
chased from Avanti Polar Lipids (Alabaster, AL). Antibodies
against acetyl-CoA carboxylase1, p-ACC1S79, AMP-activated
kinase (AMPK), p-AMPKT172, cortactin, p-SrcY416, and Src
were purchased from Cell Signaling Technologies (Beverly, MA).
Antibody against fatty acid synthase was purchased from BD
Transduction Labs (San Diego, CA). Antibody against b-actin was
purchased from Sigma-Aldrich (St. Louis, MO). Antibody against
neural Wiskott-Aldrich syndrome protein (N-WASp) was pur-
chased from Santa Cruz Biotechnology (Santa Cruz, CA).
Secondary antibodies were purchased from Bio-Rad Laboratories
(Hercules, CA). Cell culture and AlexaFluor reagents were
purchased from Invitrogen (Carlsbad, CA).
Cell Lines and Culture Conditions
The established cell lines MDA-MB-231, PC-3, Snb19 and
293T were obtained from the American Type Tissue Collection
(ATCC). The human cell lines for this study were determined to
be exempt by the Institutional Review Board of Wake Forest
University. Wild type and stearoyl-CoA desaturase-1 deficient cell
lines (SCD-1
+/+ and SCD-1
2/2) were described previously [30].
Parental 3T3 and 3T3+Src(Y527F) were described previously
[10]. The 3T3, 3T3+Src(Y527F), MDA-MB-231, and Snb19 cells
were maintained in DMEM. The PC-3 cells were maintained in
RPMI-1640. All media were supplemented with 10% fetal bovine
serum (FBS), penicillin/streptomycin, and cultured in 5% CO2 at
37uC. Primary SCD-1
+/+ and SCD-1
2/2 MEFs were immortal-
ized using the 3T3 growth crisis protocol [31]. The pBABE/puro-
Src(Y527F) retroviral vector was transfected into 293T packaging
cells with lipofectamine 2000 (Invitrogen, Carlsbad, CA). Condi-
tioned media containing viral particles was harvested then applied
to SCD-1
+/+ and SCD-1
2/2 MEFs in a 1:1 ratio in medium
supplemented with 4 mg/mL polybrene. The MEFs were infected
for 24 hours then selected with 2 mg/mL puromycin in normal
growth medium followed by maintenance in growth medium
containing 1 mg/mL puromycin. Levels of p-Src(Y416) and total
Src were analyzed by immunoblot (see Immunoblot Analysis) in stable
populations of SCD1
+/+-Src and SCD1
2/2-Src cells.
Metabolic Labeling
3T3 and 3T3-Src cells were seeded in 24-well plates at a density
of 8610
4 cells/well. After 24 hours the cells were treated with
vehicle (Dimethyl sulfoxide (DMSO, 0.1%) or TOFA (30 mM) for
2 hours. In the AMPK studies, the cells were treated with vehicle
(dH2O) or AICAR (2.5 mM) for 16 hours. To label newly
synthesized fatty acid, cells are pulsed with 1 mCi
14C-acetate
(GE Healthcare, Piscataway, NJ) for 2 hours, washed with
phosphate buffered saline (PBS), and lysed in hypotonic buffer
(1 mM dithiothreitol (DTT), 1 mM ethylenediaminetetraacetic
acid (EDTA), 20 mM Tris, pH 7.5). Lipids were extracted with
chloroform:methanol (2:1 v/v) and
14C-acetate incorporation was
quantified by scintillation counting as previously described [32].
Invadopodia Visualization
For inhibitor studies, 3T3-Src cells were seeded in 6-well plates
containing glass cover slips at a density of 1610
5 cells/well then
treated with vehicle (DMSO 0.1%), TOFA (30 mM), or CP640186
(100 mM) for 24 hours before coverslip collection. For siRNA
studies, ACC was knocked down as outlined in the following
section for 48 hours before coverslip collection. For AMPK
studies, the pre-plated cells were treated with AICAR (2.5 mM) for
16 hours. For fatty acid rescue experiments, 3T3-Src cells were
treated with vehicle (DMSO 0.1%, 1% BSA) and TOFA, or
AICAR in the absence or presence of 300 mM 16:0 or 18:1 fatty
acid. For the lipid rescue experiments, cells were treated with
vehicle (DMSO 0.1%-EtOH 0.04%) and TOFA or AICAR, in the
absence or presence of 150 mM 30:0 PC or 300 mM 34:1 or 36:2
PC. For the experiments examining the role of SCD-1 in
invadopodia, SCD1
+/+-Src and SCD1
2/2-Src cells were seeded
at 1610
5 cells/well and grown on glass coverslips for 24 hours
before coverslip collection. The coverslips were washed with PBS
and fixed with 4% paraformaldehyde. The cells were permea-
blized with 0.1% Triton X-100 in PBS followed by staining with
AlexaFluor488-phalloidin in 5% donkey serum-PBS for 1 hour
and 49,6-diamidino-2-phenylindole (DAPI, 1 mg/mL in PBS for
5 min) before mounting onto glass slides. For co-staining, fixed
cells were incubated with a primary antibody against cortactin in
5% donkey serum-PBS for 1 hour followed by incubation with
AlexaFluor488-phalloidin, 5% donkey serum-PBS for 1 hour,
AlexaFluor594-secondary antibody in 5% donkey serum-PBS for
1 hour, and DAPI (1 mg/mL in PBS for 5 min). The coverslips
were mounted onto glass slides. Images were collected in the Cell
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microscope equipped with a 406 Plan-Neofluor (numerical
aperture 1.3) and 636PlanApochromat (numerical aperture 1.4)
objectives, a Zeiss AxioCam digital camera, and Axioplan 2.05
imaging software. All merging and linear processing of images was
done using Adobe Photoshop CS2. Invadopodia were defined as
punctuate dots and rosettes were defined as O-like structures and
quantified by counting a minimum of 200 cells per treatment.
siRNA Knockdown of ACC
3T3-Src cells were plated into 10 cm dishes. After 24 hours, the
cells were transfected with 100 nM of either of two independent
siRNAs specific for ACC1 (siRNA#1, GUAGAAAUCAAAU-
UCCGUAUUUU or siRNA#2, CAAGACUGAUGGCGAUA-
UU) (Dharmacon, Lafayette, CO) or scrambled siRNA (100 nM)
using either siPORT NeoFX (Ambion, Austin, TX) or Lipofecta-
mine 2000 (Invitrogen, Carlsbad, CA). After 48 or 72 hours, the
cells were processed for invadopodia visualization or invasion
assay, respectively, and protein was harvested for analysis by
immunoblot (see Immunoblot Analysis). In the case of fatty acid and
lipid supplementation, the indicated fatty acid or lipid were added
24 hours before processing the cover slips.
Immunoblot Analysis
Protein was harvested by scraping cells into media then pelleting
by centrifugation. The cells were washed with ice cold PBS then
lysed in ice cold buffer (20 mM Tris, pH 8.3, 5 mM EDTA, 1%
Triton X-100) supplemented with a protease and phosphatase
inhibitor cocktail (5 mg/mL aprotinin, 5 mg/mL leupeptin, 5 mg/
mL pepstatin A, 1 mM sodium orthovanadate, 1 mM sodium
fluoride, 0.1 mM okadeic acid, and 200 mM phenylmethylsulfonyl
fluoride). Proteins were separated by SDS-PAGE through 13.5%,
10%, or 7.5% gels and transferred to nitrocellulose membrane.
After incubation with appropriate antibodies, immunoreactive
proteins were detected with enhanced chemiluminescence (Perkin
Elmer, Waltham, MA). b-actin or b-tubulin was used as loading
control. Immunoreactive bands were quantified by densitometry
using the ImageJ program.
Phospholipid Analysis
3T3-Src or PC-3 cells were treated with vehicle (DMSO 0.1%)
or TOFA (30 mM) for 24 hours then the treated cells were
trypsinized, pelleted by centrifugation, washed with ice cold 0.9%
saline, and snap frozen in liquid nitrogen. Lipid was extracted
from the cell pellets using the method of Bligh and Dyer [33] and
suspended in 1:1 chloroform:methanol (v:v). The total phospho-
rous levels were determined according to the method of Rouser et
al [34]. The lipid samples were diluted to 2 nmol/mL phospho-
rous with chloroform/methanol containing 1% formic acid. The
phospholipid profiles were analyzed using a TSQ Discovery Max
electrospray ionization triple quadrupole mass spectrometer using
the specifications outlined by DeLong, et al [35]. The PC, PE and
PS profiles were analyzed in the positive ion mode by analyzing
the spectra around the neutral loss of m/z 184.1, 141.1, and 185.1,
respectively. The PI profile was analyzed in the negative ion mode
by analyzing the precursor spectra of m/z 241.1.
Phospholipid classes were analyzed as outlined by Van Kessel, et
al. [36] in 3T3-Src or PC-3 cells treated with vehicle (DMSO 0.1%)
or TOFA (30 mM) for 24 hours. Briefly, cellular lipids were
extracted as above then applied to a 300 mm Waters mPorasil
column that has a 10 mm particle size. Lipid classes were separated
using gradient elution with the following buffers: A - hexane :
isopropanol : water : ammonium hydroxide (150:200:5:2, v/v); B -
hexane : isopropanol : water : ammonium hydroxide (150:200:35:2,
v/v); and C - chloroform : isopropanol (1:1 v/v). Total phosphorus
content of eachlipid class wasdetermined accordingto Rouser,et. al
[34]. The absolute pmol phospholipid in each sample was
calculated from the mol% reading and the phospholipid class
analysis then normalized to nmol phosphorus (P).
Invasion Assays
3T3-Src (2610
4), MDA-MB-231 (2610
4), Snb19 (2610
4), or
PC-3 (1.75610
4) cells were seeded into the top well of an invasion
chamber fitted with a matrigel coated porous membrane (BD
Biocoat, Franklin Lakes, NJ) in media with 0.1% FBS. For
inhibitor studies, the cells were seeded in the presence of vehicle
(DMSO 0.1%) or TOFA (30 mM). For lipid rescue studies, the
cells were seeded in the presence of the following: vehicle (DMSO
0.1%, EtOH 0.04%); TOFA (30 mM), or TOFA plus 300 mM
34:1 or 36:2 PC species. Invasion assays were incubated for
24 hours. Cells that migrated to the underside of the membrane
were fixed with 10% methanol:10% acetic acid (v:v) for 30 min,
stained with 0.4% crystal violet (30 min) and counted.
Gelatin Degradation and Zymography Analysis
3T3-Src cells were plated in 6-well plates with glass coverslips
coated with AlexaFluor488 labeled gelatin at a density of 1.5610
5
cells/well [37]. The cells were treated with vehicle (0.1% DMSO)
or TOFA (30 mM) and gelatin degradation proceeded for
24 hours. The cells were then fixed with paraformaldehyde and
stained with AlexaFluor594-phalloidin and DAPI as outlined in
Invadopodia Visualization. For siRNA experiments, the cells were
treated with ACC1-targeting siRNA for 24 hours (as in siRNA
knockdown of ACC1) then plated onto gelatin-coated coverslips and
processed as above. For AMPK studies, 3T3-Src cells were treated
with AICAR (2.5 mM) for 16 hours then processed as above.
Fatty acid and lipid rescue experiments were performed as
described above. Degradation area per cell was determined using
ImageJ. For zymography analysis, 3T3-Src cells were seeded in 6-
well plates at a density of 2.0610
5 cells per well. After 6 hours the
media was replaced with OptiMem reduced serum media. After
16 hours, the cells were treated with vehicle (DMSO 0.1%, 1%
BSA), TOFA (30 mM), or TOFA +75, 150, or 300 mM 18:1 fatty
acid. After 48 hours the conditioned media was removed and
proteins were resolved a 10% zymography gel. The gel was
incubated in PBS buffer containing 2.5% Triton X-100 then
developed for 24 hours at 37uC in buffer containing 50 mM Tris,
pH 7.5, 5 mM CaCl2?2H2O, 200 mM NaCl, 0.02% Brij-35. The
zymogram was stained in buffer containing 40% methanol, 10%
acetic acid, and 0.5% Coomassie Blue R-250 followed by
destaining in buffer containing 40% methanol and 10% acetic
acid in dH2O.
Clonogenic and Proliferation Studies
3T3-Src cells were plated into 6-well plates at 400 cells/well in
the presence of vehicle (DMSO 0.1%) or TOFA (30 mM). The
cells were treated for 16 hours, then the media was replaced with
normal growth medium and colonies developed for 6–9 days. The
colonies were fixed with 10% methanol and 10% acetic acid for
10 min followed by staining with 0.4% crystal violet for 30 min,
washed, dried and quantified by counting. To measure prolifer-
ation 3T3-Src cells were seeded at a density of 5610
4 cells/well
and allowed to adhere for 24 hours. The cells were treated with
vehicle (DMSO 0.1%) and TOFA (30 mM) for 24 hours. For
counting, the cells were trypsinized, pelleted by centrifugation and
resuspended in cold PBS/trypan blue. Viable cells were
determined by exclusion of trypan blue.
Acetyl-CoA Carboxylase Is Required for Invadopodia
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Statistical significance between two groups was determined by
Student’s t-test. Error bars for all graphs represent standard
deviation except the graphs quantifying gelatin degradation, which
represents standard error of the mean.
Results
Acetyl-CoA carboxylase 1 activity is required for
invadopodia
To determine whether fatty acid synthesis has a role in Src
mediated invadopodia formation, the expression and activity of
the fatty acid synthesis pathway was determined in 3T3 cells and
3T3 cells transformed with constitutively active Src (3T3-Src) [38].
Transformation with Src increased fatty acid synthesis approxi-
mately three-fold and also increased ACC1 and FASN protein
levels (Fig. 1A, p#0.05). Inhibition of ACC in 3T3-Src cells by the
non-isozyme selective inhibitor 5-(Tetradecyloxy)-2-furoic acid
(TOFA) decreased fatty acid synthesis by approximately 83%
(Fig. 1B, p#0.01). Pharmacological inhibition of ACC activity
with TOFA or CP-640186 [39] resulted in a dramatic reduction in
invadopodia incidence (Fig. 1C). TOFA treatment reduced
punctate invadopodia (indicated by arrowhead in control
micrograph) by 41% and rosettes (indicated by arrow in control
micrograph) by 49% (p#0.05), and CP-640186 treatment reduced
invadopodia by 39% and rosettes by 60% (p#0.05). Along with
invadopodia loss, pharmacological inhibition of ACC also induced
morphological changes such as cell enlargement (Fig. 1C). Because
TOFA and CP-640186 inhibit both ACC1 and ACC2, we also
assessed invadopodia following specific ACC1 knockdown with
siRNA because of its role in fatty acid synthesis. Transfection of
3T3-Src cells with two independent siRNAs against ACC1
Figure 1. ACC1 activity is required for invadopodia formation. (A) Fatty acid synthesis was determined by incorporation of
14C-acetate into
lipid in 3T3 and 3T3-Src cells. Protein expression of ACC1, FASN, and b-tubulin were determined by immuno-blot. (B) 3T3-Src cells were treated with
vehicle or TOFA (30 mM) for 2 hours and fatty acid synthesis was determined as in A. (C) 3T3-Src cells were treated with vehicle, TOFA (30 mM), or
CP640186 (100 mM) for 24 hours. Invadopodia and rosettes were visualized by staining cells with AlexaFluor488-phalloidin. Arrowhead indicates
punctate invadopodia and arrow indicates rosette superstructure. (D) 3T3-Src cells were transfected with 100 nM scrambled (Sc) or two independent
ACC1-specific siRNAs (siRNA #1o r#2) for 48 hours. Invadopodia were quantified after AlexaFluor488-phalloidin staining. ACC1 and b-actin protein
levels were analyzed by immune-blot. (E) 3T3-Src cells were treated with vehicle or TOFA (30 mM) for 16 hours and clonogenic survival was
determined. (F) 3T3-Src cells were treated with vehicle or TOFA (30 mM) for 24 hours and viable cells were quantified by trypan blue exclusion. (G)
3T3-Src cells were transfected with 100 nM scrambled or siRNA #1 against ACC1 as in D. Expression of the indicated proteins was analyzed by
immunoblot. Scale bar, 25 mm. *p#0.05; **p#0.01; ***p#0.001.
doi:10.1371/journal.pone.0029761.g001
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(p#0.0005) compared to cells transfected with scrambled siRNA
(Fig. 1D). Although TOFA treatment did not have a significant
impact on clonogenic survival, it did reduce proliferation of the
Src transformed cells (Fig. 1E&F). Interestingly, knockdown of
ACC1 reduced invadopodia incidence, independent of changes in
expression of invadopodia-associated proteins like cortactin, N-
WASp and Tks5 (Fig. 1G). Together, these data demonstrate that
ACC1 is required for proper invadopodia assembly.
Restoration of invadopodia incidence by fatty acid
Because ACC1 catalyzes the rate-limiting step of fatty acid
synthesis (Fig. 1B), the ability of exogenous fatty acid to restore
invadopodia incidence in TOFA-treated 3T3-Src cells was
determined. The addition of 16:0 fatty acid (palmitate) increased
the percentage of TOFA-treated cells making invadopodia from
40% of control to 89% of control (p#0.02, Fig. 2A). Palmitate did
not restore rosette formation, however (Fig. 2A). Supplementation
with 18:1 fatty acid (oleate) increased the percentage of cells with
invadopodia from 29.6% of control to 95.0% of control and the
percentage of cells with rosettes to 72% of control (p#0.01,
Fig. 2B). The ability of 18:1 fatty acid to restore invadopodia in
cells transfected with two ACC1-specific siRNAs was also
determined. The addition of 18:1 fatty acid to cells transfected
with siRNA against ACC1 completely restored the incidence of
cells making invadopodia and rosettes (Fig. 2C, p#0.02), without
affecting ACC1 knockdown (Fig. 2D). It is worth noting that the
addition of 18:1 fatty acid to 3T3-Src cells did not affect
invadopodia formation on its own (Fig. 2F). The addition of
18:1 fatty acid to TOFA-treated cells also restored cortactin
localization to focalized actin in invadopodia (Fig. 2E). These data
support the notion that de novo fatty acid synthesis is required for
maintenance of invadopodia structures in 3T3-Src cells.
Because 18:1 fatty acid is able to restore both invadopodia and
rosettes in cells with disrupted ACC1 activity, we determined
whether loss of stearoyl-CoA desaturase 1 (SCD-1), the enzyme
that generates 18:1, affects invadopodia incidence. Wild-type and
SCD-1deficient MEFs [30] were transformed with constitutively
Figure 2. Fatty acid restores invadopodia following ACC1 inhibition. (A) Invadopodia incidence in 3T3-Src cells treated with vehicle, TOFA
(30 mM), or TOFA +16:0 fatty acid for 24 hours. (B) Invadopodia incidence in 3T3-Src cells treated with vehicle, TOFA (30 mM), or TOFA +18:1 fatty acid
for 24 hours. (C) Invadopodia incidence in 3T3-Src cells transfected with 100 nM scrambled (Sc) siRNA or siRNA #1 against ACC1 for 48 hours and
then supplemented with 18:1 fatty acid for 24 hours. (D) ACC1 protein expression in 3T3-Src cells transfected with 100 nM scrambled or siRNA #1
against ACC1 and supplemented with 18:1 fatty acid. (E) Cortactin localization to invadopodia in 3T3-Src cells treated with vehicle, TOFA (30 mM), or
TOFA supplemented with 18:1 fatty acid for 24 hours. Cortactin co-localization with F-actin was determined by immunofluorescence. Scale bar,1 mm.
(F) 3T3-Src cells were treated with BSA or 18:1 fatty acid for 24 hours and invadopodia incidence was determined. Scale bar, 25 mm* p #0.05;
**p#0.01.
doi:10.1371/journal.pone.0029761.g002
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+/+ and Src-SCD-1
2/2) and invadopodia
incidence was quantified. The absence of SCD-1 had no effect on
invadopodia incidence (Fig. 3A, p#0.90), Src expression or
SrcY416 phosphorylation (Fig. 3B). These data imply that the
effects of ACC1 inhibition on invadopodia are not solely due to
loss of 18:1 levels, but rather to decreases in total fatty acid
synthesis.
Inhibition of ACC1 affects the lipid profile of 3T3-Src cells
To elucidate the connection between lipogenesis and invado-
podia the lipid profile of 3T3-Src cells treated with TOFA was
determined by mass spectrometry. Blockade of ACC activity most
dramatically altered the phosphatidylcholine (PC) profile of 3T3-
Src cells. Consistent with the role of ACC1 in de novo fatty acid
synthesis, TOFA treatment reduced the levels of virtually all PC
species containing saturated and monounsaturated fatty acids
(Table 1). For example, 30:0 PC levels decreased from 19.7 pmol/
nmol phosphorous to 6.6 pmol/nmol phosphorous, 34:1 PC
decreased from 78.2 pmol/nmol phosphorous to 47.6 pmol/nmol
phosphorous and 36:2 PC decreased from 28.6 pmol/nmol
phosphorous to 18.3 pmol/nmol phosphorous. Conversely, inhi-
bition of ACC activity resulted in a shift away from the saturated
and monounsaturated species towards the polyunsaturated species
as has been demonstrated previously [40]. Among the increased
polyunsaturated species, the largest increases were observed in the
36:4, 36:5, and 38:5 PC species with each increasing approxi-
mately 2-fold (Table 1, p,0.0001). Taken together, these data
demonstrate that ACC activity is important for maintaining the
PC composition in 3T3-Src cells.
The profiles of phosphatidylethanolamine (PE), phosphatidyl-
serine (PS), and phosphatidylinositol (PI) are also affected by ACC
inhibition (Table 1). Interestingly, most of the species in these
phospholipid classes did not contain saturated or mono-unsatu-
rated fatty acids that would be derived from ACC1 activity. For
example, the most abundant PE species, 38:4 PE and 38:5 PE, are
not significantly changed following TOFA treatment. Similarly,
the most abundant species of PI, 38:4 PI, was not changed. The
few species in each class that did contain saturated and mono-
unsaturated fatty acid were reduced, and the species containing
poly-unsaturated fatty acid were increased in relative abundance
(Table 1). Overall, the effect of ACC inhibition in 3T3-Src on the
PC profile suggests a role for PC in invadopodia formation.
The contribution of specific PC species to invadopodia
formation in cells with depleted ACC1 activity was also
determined. We specifically focused on PC species because they
are the most abundant phospholipid species, are a primary sink for
de novo synthesized fatty acids, and were highly affected by ACC
inhibition (Table 1) [17,41]. Three PC species that represent small,
moderate, and large percentages of total PC were used to
determine the contribution of individual lipids to invadopodia
formation. The ability of 30:0 PC, 36:2 PC, and 34:1 PC to rescue
invadopodia incidence following treatment with TOFA or
transfection with ACC1-siRNA was determined. Although TOFA
treatment reduced 30:0 PC levels by 66% (Table 1), exogenous
30:0 PC did not restore invadopodia in TOFA-treated 3T3-Src
cells (Fig. 4A&C, p#0.6), and higher concentrations of 30:0 PC
were toxic (data not shown). On the other hand, 34:1 PC restored
invadopodia incidence in TOFA-treated 3T3-Src cells from 59%
to 99% of control (Fig. 4A&C, p#0.002), and 36:2 PC restored
invadopodia incidence from 44% to 89% of control, respectively
(Fig. 4A&C, p#0.03). Interestingly, none of the PC species were
able to completely rescue rosette superstructure formation
although partial restoration was observed following exogenous
34:1 and 36:2 PC treatments (Fig. 4A&C). Similar results were
obtained when these lipids were added to cells transfected with
ACC1-specific siRNA (Fig. 4B&C). As in TOFA treated cells, the
addition of 30:0 PC to cells transfected with ACC1-specific siRNA
did not restore invadopodia incidence (Fig. 4B&D). The addition
of 34:1 PC to 3T3-Src cells transfected with ACC1-directed
siRNA restored invadopodia incidence to 88% of control levels
Figure 3. Stearoyl-CoA desaturase-1 is not required for invadopodia formation. (A) Invadopodia incidence was determined in wild-type
(SCD1
+/+) and SCD-1 deficient (SCD1
2/2) MEFs transformed with Src(Y527F). (B) SCD1
+/+ and SCD1
2/2 MEFs transformed with Src(Y527F) were
harvested, lysed, and p-SrcY416, total Src and b-actin levels were determined by immunoblot blot. Scale bar, 25 mm.
doi:10.1371/journal.pone.0029761.g003
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(Fig. 4B&D). These data support a novel role for PC species in
invadopodia assembly.
ACC1 is required for invadopodia-mediated gelatin
degradation
Because invadopodia are linked with cellular invasion, we
determined the effect of inhibiting ACC1 on the ability of 3T3-Src
cells to degrade a gelatin matrix. Similar to the effect on
invadopodia incidence (Fig. 1), TOFA treatment diminished the
gelatin degrading activity of 3T3-Src cells by 60% (Fig. 5A,
p#0.001). The addition of 16:0 and 18:1 fatty acid restored the
gelatin degrading capacity of TOFA-treated 3T3-Src cells to levels
equal to or exceeding control (Fig. 5A, p#0.05). Similarly, 48-hour
knockdown of ACC1 decreased gelatin degradation by approxi-
mately 50%, which was completely restored by the addition of
18:1 fatty acid (Fig. 5B, p#0.05). Gelatin zymography was used to
measure matrix metalloproteinase (MMP) activity in conditioned
media from TOFA-treated 3T3-Src cells. Consistent with the
effects on gelatin degradation in situ, TOFA treatment reduced the
level of secreted MMP-2 that was restored by the addition of 18:1
fatty acid (Fig. 5C). The ability of PC species to restore gelatin-
Table 1. ACC inhibition alters the phospholipid profiles of 3T3-Src cells.
PC (pmol/nmol P) PE (pmol/nmol P) PS (pmol/nmol P) PI (pmol/nmol P)
Control TOFA Control TOFA Control TOFA Control TOFA
30:0 19.760.8 6.660.2* -- - ---
30:1 6.960.4 2.360.5* -- - ---
32:0 31.461.3 25.660.3* -- - ---
32:1 64.561.6 24.460.7* -- 0 . 3 60.2 0.660.5 - -
32:2 11.360.5 3.860.2* -- - ---
32:3 -- -- 1 . 4 60.5 0.360.4 - -
32:4 -- -- 1 . 1 60.4 1.060.6 - -
34:0 7.860.4 8.660.5* 0.860.6 0.560.6 - - - -
34:1 78.262.2 47.661.1* 9.962.5 3.061.0* 3.562.4 2.260.5 - -
34:2 40.361.2 20.360.6* 5.8610 . 8 60.5* 0.760.5 0.660.4 - -
34:3 5.060.05 3.860.3* -- 1 . 8 60.8 0.960.7 - -
34:4 -- -- 5 . 9 61.1 1.860.9* - -
34:5 -- -- 0 . 8 60.4 0.360.3 - -
36:0 2.161.4 2.860 . 4 -- - ---
36:1 9.960.8 8.160.4* -- 5 . 9 61.1 3.260.9 0.760.8 0.460.8
36:2 28.660.9 18.360.8* 0.860.6 0.560.6 2.160.7 1.460.5* 5.561.9 1.961.0*
36:3 9.260.3 17.860.5* 9.962.5 3.061.0* 1.561.0 0.860.6 3.462.3 0.660.8
36:4 7.960.3 36.661.9* 5.8610 . 8 60.5* 4.461.5 1.860.8 2.360.6 0.860.5*
36:5 2.360.2 9.160.2* -- 2 . 2 61.7 1.560.4* --
38:0 3.660.2 3.360 . 3 -- - ---
38:1 -- -- - -0 . 6 60.9 0.360.6
38:2 1.161.3 2.860.6 2.160.8 1.160.2* - ---
38:3 4.060.8 7.460.8* 8.163.0 5.860.7 1.360.7 1.960.8* 8.963.2 8.962.7
38:4 9.460.4 30.960.9* 33.563.6 35.860.7 1.760.6 2.560.7* 35.369.7 37.164.7
38:5 9.960.5 42.061.2* 15.462.6 18.762.4 2.461.1 1.560.6 15.364.0 11.063.7
38:6 4.060.2 10.960.5* 3.261.3 5.961.7* 0.660.6 1.760.6 - -
38:7 -- 1 . 2 60.6 2.360.8 0.760.8 3.662.0 - -
38:8 -- 0 . 8 60.6 1.360.3 - - - -
40:4 -- 4 . 2 61.4 3.860.5 2.060.8 1.760.8 - -
40:5 2.960.3 6.460.3* 6.761.7 9.961.5* 4.061.6 5.160.7 1.261.4 5.661.6*
40:6 4.160.2 8.160.2* 20.165.8 10.561.2* 4.061.2 3.262.1 1.160.8 5.061.0*
40:7 3.260.3 6.460.5* 11.162.0 10.360.8 1.560.9 2.160.6 - -
40:8 -- 1 . 8 60.7 4.360.8* 0.760.6 3.861.1 - -
40:10 -- -- 0 . 3 60.3 0.660.2 - -
42:9 -- -- 0 . 4 60.5 0.660.5 - -
42:10 -- -- 0 . 5 60.6 0.860.3 - -
- Not Detected.
*p#0.05.
doi:10.1371/journal.pone.0029761.t001
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investigated. Consistent with a lack of effect on invadopodia, the
addition of 30:0 PC to TOFA-treated 3T3-Src cells did not restore
the gelatin degrading activity of the cells (Fig. 6). On the other
hand, 34:1 PC and 36:2 PC restored the gelatin degrading activity
of TOFA-treated 3T3-Src cells to approximately 95% of control
(Fig. 6, p#0.05).
Inhibition of fatty acid synthesis by AMPK reduces
invadopodia incidence
We next determined whether inhibition of fatty acid synthesis
through another mechanism could negatively impact invadopodia.
Because ACC1 activity can be shut down via phosphorylation by
the AMPK, the effect of AMPK activation on invadopodia
formation and activity was assessed. Treatment with AICAR
activated AMPK and induced a 2-fold increase in ACC1
phosphorylation (Fig. 7A), which corresponded with a 90%
reduction in fatty acid synthesis (Fig. 7B, p#0.05). Similar to the
effects of ACC1 inhibition, AMPK activation and subsequent
ACC1 phosphorylation reduced invadopodia incidence to 39% of
control and rosette incidence to 27% of control (Fig. 7C, p#0.05).
The addition of 16:0 or 18:1 fatty acid and 34:1 PC to AICAR-
treated cells restored invadopodia presence to 81, 91, and 86% of
control, respectively (Fig. 7C, p#0.05). The addition of 34:1 PC to
AICAR-treated cells also restored rosette formation to 92% of
control, whereas the addition of 16:0 or 18:1 fatty acid did not
significantly rescue rosette incidence (Fig. 7C, p#0.05). Consistent
with the effect on invadopodia incidence, AICAR treatment also
reduced gelatin degradation to 49% of control (Fig. 7D&E,
p#0.05). The addition of 16:0 or 18:1 fatty acid and 34:1 PC to
AICAR-treated cells restored gelatin degradation to 94, 172, and
106% of control levels, respectively (Fig. 7D&E, p#0.05).
Collectively, these data demonstrate that modulation of fatty acid
synthesis through AMPK activation and ACC phosphorylation
also impacts on invadopodia incidence and activity.
ACC activity is required for cellular invasion
Because inhibition of ACC1 decreased invadopodia incidence
and impaired the capacity of 3T3-Src cells to degrade gelatin, the
impact on the invasive capacity of cells was also determined.
Transfection of 3T3-Src cells with ACC1-specific siRNA reduced
invasion through matrigel-coated membranes by 50% compared
to cells transfected with scrambled siRNA (p#0.01, Fig. 8A).
Treatment of 3T3-Src cells with TOFA also reduced invasion
through matrigel-coated membranes to 37% of control (Fig. 8B&C,
p#0.01). Interestingly, even though 36:2 PC was able to fully
restore invadopodia incidence in TOFA-treated cells, 36:2 PC did
not restore the ability of TOFA-treated 3T3-Src to invade through
matrigel (p#0.9; Fig. 8B). On the other hand, the addition of 34:1
PC completely restored the invasive capacity of TOFA-treated
3T3-Src cells to control levels (p#0.004, Fig. 8C). These data
clearly demonstrate that fatty acid and lipid synthesis are required
for cellular invasion, but that specific lipid species have defined
roles in the invasive process.
Figure 4. Specific phosphatidylcholine species restore invadopodia formation in 3T3-Src cells with impaired ACC activity. (A)
Invadopodia incidence in 3T3-Src cells that were treated with vehicle, TOFA (30 mM), or TOFA supplemented 30:0 PC, 34:1 PC, or 36:2 PC. (B)
Invadopodia incidence in 3T3-Src cells transfected with 100 nM scrambled (Sc) or siRNA #1 against ACC1 and supplemented with 30:0 PC or 34:1 PC.
(C) Quantification of A. (D) Quantification of B. Scale bar, 25 mm. *p#0.05; **p#0.01.
doi:10.1371/journal.pone.0029761.g004
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MB-231, Snb-19, and PC-3 human tumor cell lines, representing
breast cancer, glioblastoma, and prostate cancer, respectively, was
also determined. TOFA treatment reduced invasion of MDA-MB-
231 and Snb19 cells through matrigel-coated membranes by 84%
(p#0.01) and 67% (p#0.01), respectively (Fig. 8D&E). TOFA
treatment also reduced the invasion of PC-3 cells through
matrigel-coated membranes by 74% (p#0.0001, Fig. 8G). The
addition of 34:1 PC, which was reduced by TOFA treatment
(Fig. 8F), restored the invasive capacity of TOFA-treated PC-3
cells to 87% of control (p#0.02, Fig. 8G). Combined with data
demonstrating a role for ACC1 in invadopodia, these data suggest
that ACC1 contributes to the lipid-dependent regulation of human
tumor cell invasion.
Discussion
Given the ubiquitous association of the fatty acid synthesis
pathway in cancer, it is critical to clarify the roles the pathway
plays in determining the behavior and function of tumor cells.
Increased fatty acid synthesis has been noted in multiple cancers
[18] and expression is associated with more aggressive disease
[19,20,21,22,23,24,25,26,27,28,42]. Even though de novo fatty acid
synthesis is clearly associated with membrane biogenesis, the
mechanism by which the pathway regulates the processes of tumor
cell invasion and migration has remained undefined. The data
presented herein demonstrate that ACC1 is required for
invadopodia formation and the invasive ability of tumor cells.
It has been demonstrated that in tumor cells most fatty acid that
is synthesized de novo incorporates into glycerophospholipids and is
used for membrane biogenesis [17]. Concomitant with this
finding, it is also evident that much of the de novo synthesized
fatty acid is enriched in lipid raft-like domains [17]. Conversely,
inhibition of fatty acid synthesis appears to disrupt lipid raft
domains. This is consistent with the notion that lipid rafts are
primarily composed of phospholipids with saturated fatty acyl tails,
along with cholesterol and sphingolipids [43]. This, combined with
our finding that inhibition of fatty acid synthesis disrupts
invadopodia (Fig. 1), suggests that fatty acid synthesis contributes
to invadopodia by coordinating and maintaining lipid raft
structures. Further support of this notion is the fact that lipid
rafts are enriched at sites of invadopodia. Depletion of cholesterol
Figure 5. Fatty acid addition rescues gelatin degradation in 3T3-Src cells treated with TOFA. (A) Gelatin degradation of 3T3-Src cells
seeded on glass cover slips coated with AlexaFluor-488 conjugated gelatin in the presence of vehicle, TOFA (30 mM), or TOFA with 18:1 or 16:0 fatty
acid. Nuclei were visualized by staining with DAPI and actin was visualized with Alexafluor594-phalloidin. (B) Quantification of gelatin degradation by
3T3-Src cells transfected with scrambled (Sc) or siRNA #1 against ACC1 and supplemented with 18:1 fatty acid for 24 hours. (C) Gelatin zymography
of secreted MMP-2 in condition media from 3T3-Src cells treated with vehicle, TOFA (30 mM), or TOFA supplemented with 18:1 fatty acid for 48 hours.
Scale bar, 25 mm. *p#0.05.
doi:10.1371/journal.pone.0029761.g005
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activity and reduces localization of the raft-associated protein
caveolin-1 to invadopodia. [11,12]. The transmembrane protease
ADAM12, which also interacts with Tks5, is also known to localize
to lipid rafts and caveolin 1 [44]. Taken together, these findings
further connect lipid rafts and invadopodia.
Invadopodia are complex structures that require the coordinat-
ed interaction between the cellular membrane and the cytosolic
invadopodia components [1]. Accordingly, several lipid species are
intimately involved at sites of invadopodia nucleation, specifically,
PI(3,4)-P2, PI(3,4,5)-P3, and PI(4,5)-P2 [8,45]. Invadopodia initiate
at focal adhesions where PI(3,4)P2 is enriched upon Src activation
[8]. The activity of the p110a subunit of PI3 kinase is also
necessary for invadopodia formation in breast cancer cells [9].
Several proteins encoding lipid-binding domains mediate the
connection of invadopodia machinery to the cell membrane. For
example, Tks4 and Tks5 bind to PI(3)-P and PI(3,4)-P2 through
their PX domains [46,47]. Moreover, the interaction of Tks5 with
PI(3,4)P2 leads to a Tks5-Grb2 complex that is required for
invadopodia formation [8]. In addition, N-WASp and dynamin
bind PI(4,5)-P2 through their PH domains [48,49], and gelsolin
binds PI(3,4,5)-P3 through a non-classical PI binding domain
which facilitates podosome initiation [50,51]. Phosphoinositides
can also cluster in lipid raft domains of the cellular membrane and
cytoskeleton-membrane interactions can occur at sites of lipid rafts
[52]. Although we did not profile phosphatidylinositol phosphates
(PIPs) in this study, we did identify the overall change in the lipid
profile associated with inhibition of fatty acid synthesis and loss of
invadopodia. Importantly, the changes are consistent with what
has been reported previously [40]. Moreover, the profiles allowed
us to explore the role of specific lipid species in invadopodia.
This study focused on the contribution of fatty acids and PC
lipids to invadopodia. PC is generally the most abundant class of
glycerophopsholipids in cells and preferentially resides in the outer
leaflet of the plasma membrane [41,53]. Just as inhibition of fatty
acid synthesis through ACC1 blockade reduces invadopodia, the
addition of exogenous fatty acid to cells with depleted ACC1
activity restores them. It is interesting to note that in this system
exogenous fatty acid was able to restore invadopodia to cells with
blocked ACC1 activity, but rosettes were not always restored.
Rosettes are generally considered superstructures of multiple
invadopodia and are generally associated with Src-transformed
cells. There is little information regarding a distinct role for each
structure in the invasive process however. Regardless, our data
clearly demonstrate that a full complement of rosettes is not
required for the invasion of Src-transformed 3T3 cells. We further
demonstrated that 34:1 PC restores invadopodia (Fig. 4), restores
the capacity to degrade gelatin (Fig. 6), and rescues the invasive
capacity of tumor cells treated with ACC inhibitors or transfected
with siRNA against ACC1 (Fig. 8). The 34:1 PC species is the
most abundant glycerophospholipid species in the 3T3-Src cells
and includes 16:0 and 18:1 fatty acyl tails (Table 1). Because of
this, we surmise that exogenous addition of 34:1 PC populates the
outer leaflet of the cellular membrane and restores the ability of
cells to form lipid raft structures and to cluster PIPs appropriately
to initiate invadopodia. It does not rule out the possibility that
specific lipid-mediated signaling processes could also contribute to
the formation of invadopodia. Interestingly, the 36:2 lipid species
was able to restore invadopodia and gelatin degradation (Figs. 4&6)
but not invasion through matrigel (Fig. 8). These data suggest that
even cells with a robust presence of invadopodia could be defective
in the capacity to invade. Moreover, these findings support the
idea that specific membrane composition and architecture is
required for the processes that drive invadopodia and invasion. It
will be interesting to identify whether invadopodia components
differ in cells rescued with 36:2 PC compared to 34:1 PC. Our
Figure 6. Phosphatidylcholine supplementation restores gelatin degradation in TOFA-treated 3T3-Src cells. Gelatin degradation of
3T3-Src cells seeded on glass cover slips coated with AlexaFluor-488 conjugated gelatin in the presence of vehicle, TOFA (30 mM), or TOFA with 30:0
PC, 34:1 PC, or 36:2 PC for 24 hours. Nuclei were visualized by staining with DAPI and actin was visualized with Alexafluor594-phalloidin. Degraded
area per cell is graphed. Scale bar, 25 mm. *p#0.05.
doi:10.1371/journal.pone.0029761.g006
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invadopodia, particularly PC lipids. The data do not, however,
rule out that other lipids, PC species or other, having a role in
invadopodia and the invasive process.
Inhibition of ACC disrupts the lipid composition of the cell
membrane (Table 1). It reduces the overall level of saturated lipid
and increases the relative level unsaturated species (Table 1). In
doing so, inhibition of fatty acid synthesis may also affect the
physical properties of membrane fluctuations. Interestingly, a body
of literature has provided evidence to suggest that membrane
dynamics are an important regulator of actin polymerization. In
particular, membrane curvature in an important contributor to
podosome and invadopodia assembly and is regulated by BAR
domain containing proteins [13]. For example, Toca-1 forms
positive membrane curvatures and is known to activate the N-
WASp/Wip complex at sites of curvature [54,55,56], implying
that invadopodia and podosome initiation requires proper
membrane bending. It has also been shown that ASAP1 [57]
and FBP17 [58] are critical players in podosome formation.
Altered membrane phospholipid composition as a result of
reduced ACC activity may impair the ability of BAR domain
containing proteins to properly facilitate membrane bending and,
by extension, the activation of critical invadopodia and podosome
proteins.
There is a body of evidence that links AMPK activity to actin
dynamics and polymerization. For example, pharmacological
activation of AMPK induces astrocyte stellation characterized by
F-actin disassembly and dispersion of focal adhesion complexes
and also induces cytoskeletal rearrangement in epithelial and
endothelial cells [59,60,61]. It has also been demonstrated that
AMPK regulates secretory vesicles and virus entry through
regulation of actin-dependent processes [62,63]. Multiple effec-
Figure 7. AMPK activation induces ACC1 phosphorylation and loss of invadopodia. (A) 3T3-Src cells were treated with AICAR (2.5 mM) for
16 hours and levels of p-ACC1, total ACC, p-AMPK, total AMPK, and b-actin were assessed by immunoblot. Band intensities were quantified using
densitometry. (B) Fatty acid synthesis was determined by incorporation of
14C-acetate into lipid in 3T3-Src cells following treatment with AICAR
(2.5 mM) for 16 hours. (C) Invadopodia incidence in 3T3-Src cells that were treated with vehicle or AICAR (2.5 mM) or AICAR + 16:0 or 18:1 fatty acid
and 34:1 PC 16 hours. Invadopodia and rosettes were quantified after AlexaFluor488-phalloidin staining. (D) Gelatin degradation of 3T3-Src cells
seeded on AlexaFluor-488 conjugated gelatin coated glass coverslips in the presence of vehicle, AICAR (2.5 mM), or AICAR with 16:0 or 18:1 fatty acid
and 34:1 PC for 16 hours. Nuclei were visualized by staining with DAPI and actin was visualized with Alexafluor594-phalloidin. (E) Quantification of D.
Scale bar, 25 mm. *p#0.05.
doi:10.1371/journal.pone.0029761.g007
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demonstrate that AMPK activation is associated with loss of
invadopodia because of reduced F-actin polymerization (Fig. 7).
Moreover, the effect is associated with reduced fatty acid
synthesis, and invadopodia are rescued by the addition of fatty
acid (Fig. 7). This is consistent with a role for fatty acid
metabolism being required for membrane-cytoskeleton interac-
tions. It also suggests that decreased fatty acid synthesis and
changes in membrane lipid compositions could be the mechanism
that links AMPK activity to the effects on actin cytoskeleton
dynamics in other systems. Because AMPK has recently come to
the forefront as a therapeutic target in cancer, it is worth
exploring the ability of other AMPK activators to decrease
invadopodia and the invasive phenotype.
Although invadopodia are frequently linked to the metastatic
potential of tumor cells, a number of normal cells also utilize
podosomes to facilitate degradation of extracellular components
[1]. Osteoclasts are one type of normal cell that utilize podosomes
for motility, adhesion and function [64]. Mice lacking the
podosome protein Tks4 (SH3PXD2B) have bone abnormalities
that result in skeletal dysplasia that is associated with Frank-Ter
Haar Syndrome [65]. This suggests that loss of Tks4 could reduce
podosome function in osteoclasts and negatively affect bone
remodeling. Interestingly, mice with an aP2-Cre driven deletion
of ACC1 in bone also display skeletal growth retardation and
reduced osteoclast function [66]. Based on our observation that
ACC1 inhibition reduces invadopodia incidence and activity, it is
tempting to speculate that the bone phenotype associated with
ACC1 deletion in mice is also due to decreased podosome
activity.
Altogether, the combined data highlight the importance of
ACC1 and de novo fatty acid synthesis in regulating invadopodia
and the invasive properties of transformed cells. As mentioned
above, ACC1 also contributes to fatty acid elongation. Our data
suggest that its role in fatty acid synthesis is the predominant
factor in invadopodia in that the exogenous addition of fatty acid
restores the invadopodia phenotype to cells with blocked ACC
activity. It appears that ACC may be necessary but not sufficient
for invadopodia formation and the invasive capacity of tumor
cells. Most cancer cells express ACC1 at relatively high levels, but
only a subset of cancer cells make invadopodia. This would be
akin to what has been described for PI3-kinase and invadopodia
[9]. This study establishes a nexus between ACC1 activity,
lipogenesis and invadopodia. In doing so, it also suggests that
other lipid-regulated pathways may also be implicated in
invadopodia and the invasive process. Because ACC1 is required
for some of the processes associated with an invasive phenotype,
it may be possible that pharmacological inhibition of ACC could
reduce metastatic spread to distant sites as well as reducing
localized tumor burden.
Figure 8. ACC activity is important for invasive capabilities and lipid composition of cancer cells. (A) Invasion through matrigel-coated
invasion chambers was determined 3T3-Src cells transfected with 100 nM scrambled (Sc) or siRNA #2 against ACC1. Invasion was determined
following staining with crystal violet. (B) Invasion through matrigel-coated invasion chambers was determined in 3T3-Src cells treated with vehicle,
TOFA (30 mM), or TOFA + 36:2 PC. Invasion was quantified as in A. (C) Invasion was determined in 3T3-Src cells treated with vehicle, TOFA (30 mM), or
TOFA + 34:1 PC. (D) MDA-MB-231 or (E) Snb-19 invasion through matrigel-coated chambers in the presence of vehicle or TOFA (30 mM). (F) The levels
of 34:1 PC in PC-3 cells treated vehicle or TOFA as determined by mass spectrometry. (G) Invasion of PC-3 cells through matrigel-coated invasion
chambers in the presence of vehicle, TOFA (30 mM), or TOFA + 34:1 PC. * p#0.05; **p#0.01; ***p#0.001.
doi:10.1371/journal.pone.0029761.g008
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